Risk factors, early presentations, and clinical markers of Parkinson’s disease in Primary Care in a diverse UK population
Cristina Simonet, Jonathan Bestwick, Mark Jitlal, Aaron Ben-Joseph, Charles R. Marshall, Ruth Dobson, Soha Marrium, John Robson, Andrew J. Lees, Gavin Giovannoni, Jack Cuzick, Anette Schrag, Alastair J. Noyce
doi: https://doi.org/10.1101/2021.09.30.21264336
Cristina Simonet
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
2Department of Neurology, Royal London Hospital
Jonathan Bestwick
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
Mark Jitlal
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
3Food Standards Agency, London, United Kingdom
Aaron Ben-Joseph
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
Charles R. Marshall
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
2Department of Neurology, Royal London Hospital
Ruth Dobson
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
2Department of Neurology, Royal London Hospital
Soha Marrium
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
John Robson
4Centre for Primary Care, Wolfson Institute of Population Health, The London School of Medicine and Dentistry, Queen Mary University of London. London
Andrew J. Lees
5Reta Lila Weston Institute, Institute of Neurology, UCL and National Hospital, Queen Square
Gavin Giovannoni
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
2Department of Neurology, Royal London Hospital
7Blizard Institute, Queen Mary University of London. London
Jack Cuzick
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
Anette Schrag
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
6Department of Clinical and Movement Neuroscience, University College London Queen Square Institute of Neurology, London, United Kingdom
Alastair J. Noyce
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
2Department of Neurology, Royal London Hospital
6Department of Clinical and Movement Neuroscience, University College London Queen Square Institute of Neurology, London, United Kingdom
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.
Posted October 04, 2021.
Risk factors, early presentations, and clinical markers of Parkinson’s disease in Primary Care in a diverse UK population
Cristina Simonet, Jonathan Bestwick, Mark Jitlal, Aaron Ben-Joseph, Charles R. Marshall, Ruth Dobson, Soha Marrium, John Robson, Andrew J. Lees, Gavin Giovannoni, Jack Cuzick, Anette Schrag, Alastair J. Noyce
medRxiv 2021.09.30.21264336; doi: https://doi.org/10.1101/2021.09.30.21264336
Risk factors, early presentations, and clinical markers of Parkinson’s disease in Primary Care in a diverse UK population
Cristina Simonet, Jonathan Bestwick, Mark Jitlal, Aaron Ben-Joseph, Charles R. Marshall, Ruth Dobson, Soha Marrium, John Robson, Andrew J. Lees, Gavin Giovannoni, Jack Cuzick, Anette Schrag, Alastair J. Noyce
medRxiv 2021.09.30.21264336; doi: https://doi.org/10.1101/2021.09.30.21264336
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)